观察研究
医学
孟德尔随机化
非酒精性脂肪肝
荟萃分析
内科学
肥胖
置信区间
体质指数
流行病学
相对风险
疾病
脂肪肝
生物
生物化学
遗传变异
基因型
基因
作者
Min Seo Kim,Inhyeok Lee,Pradeep Natarajan,Ron Do,Yeongkeun Kwon,Jae Il Shin,Marco Solmi,Jong Yeob Kim,Hong‐Hee Won,Sung Soo Park
摘要
Summary We systematically reviewed observational and Mendelian randomization (MR) articles that evaluated the association between obesity and 17 gastrointestinal (GI) diseases to integrate causal and observational evidence. A total of 594 observational studies from 26 systematic reviews and meta‐analyses and nine MR articles were included. For every 5 kg/m 2 increase in body mass index (BMI), there was an increased risk of GI diseases ranging from 2% for rectal cancer (relative risk [RR]: 1.02, 95% confidence interval [CI]: 1.01 to 1.03) to 63% for gallbladder disease (RR: 1.63, 95% CI: 1.50 to 1.77). MR articles indicated that risks of developing GI diseases elevated with each 1 standard deviation increase in genetically predicted BMI, ranging from 11% for Crohn's disease to 189% for nonalcoholic fatty liver disease. Moreover, upper GI conditions were less susceptible, whereas hepatobiliary organs were more vulnerable to increased adiposity. Among the associations between obesity and the 17 GI conditions, causal relationships were inferred from only approximately half (10/17, 59%). This study reveals a substantial gap between observational and causal evidence, indicating that a combined approach is necessary to effectively inform public health policies and guide epidemiological research on obesity and GI diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI